Tirzepatide Alcohol Outcomes Study (TAOS)
This clinical trial is investigating the effects of a GLP-1-based medication, tirzepatide, on alcohol-related outcomes in adults seeking to reduce or quit drinking.
4
studies found
Biobehavioral Mechanisms Underlying Eating Regulation and Obesity Risk
The goal of this study is to better understand how brain functioning relates to mood and eating behaviors in real life. You may be eligible if you experience binge eating or have difficulties controlling your eating behavior.